Task: Answer the multiple choice question.
Question: Which drug exhibits a -31.501% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a CC(=O)Nc1ccc(NC(=O)c2c(C)nc3ccccn23)cc1
b C=CCN(Cc1nc(-c2ccccc2)no1)C(=O)c1ccc2c(c1)OCO2
Answer: b. C=CCN(Cc1nc(-c2ccccc2)no1)C(=O)c1ccc2c(c1)OCO2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C=CCN(Cc1nc(-c2ccccc2)no1)C(=O)c1ccc2c(c1)OCO2
C=CCN(Cc1nc(-c2ccccc2)no1)C(=O)c1ccc2c(c1)OCO2
N-[(3-phenyl-1,2,4-oxadiazol-5-yl)methyl]-N-prop-2-enyl-1,3-benzodioxole-5-carboxamide